XJPX
7079
Market cap40mUSD
Dec 05, Last price
2,609.00JPY
1D
-0.23%
1Q
-5.57%
IPO
-17.70%
Name
WDB coco Co Ltd
Chart & Performance
P/E
6.86
P/S
1.18
EPS
380.08
Div Yield, %
2.87%
Shrs. gr., 5y
2.03%
Rev. gr., 5y
18.44%
Revenues
5.33b
+15.91%
Net income
913m
+6.42%
CFO
1.10b
+43.00%
Dividend
Mar 30, 202695 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
WDB coco Co., Ltd. provides contract services to pharmaceutical companies in Japan. The company supports the development of pharmaceuticals and medical devices with a focus on safety information management; safety information management support; clinical research support; and post-marketing safety information management operations services. It also provides support for the preparation of various translation, and QC; clinical research support; and manpower dispatch services. In addition, the company offers post-marketing surveillance (PMS) services, such as contract conclusion with medical facilities, survey explanations, receipt of survey forms, monitoring services, including conducting re-surveys, case registration center, data management, and statistical analysis. WDB coco Co., Ltd. was incorporated in 1984 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||